Cargando…

Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein

Onchocerca volvulus is the nematode pathogen responsible for human onchocerciasis also known as “River blindness”, a neglected tropical disease that affects up to 18 million people worldwide. Helminths Excretory Secretory Products (ESPs) constitute a rich repertoire of molecules that can be exploite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Njume, Ferdinand Ngale, Ghogomu, Stephen Mbigha, Shey, Robert Adamu, Gainkam, Lea Olive Tchouate, Poelvoorde, Philippe, Humblet, Perrine, Kamgno, Joseph, Robert, Annie, Mutesa, Leon, Lelubre, Christophe, Edelweiss, Evelina, Poterszman, Arnaud, Anheuser, Susi, Vanhamme, Luc, Souopgui, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675134/ https://www.ncbi.nlm.nih.gov/pubmed/31329585 http://dx.doi.org/10.1371/journal.pntd.0007591

Ejemplares similares

Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus
por: Shey, Robert Adamu, et al.
Publicado: (2018)

The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca volvulus Excretory Secretory Products
por: Vanhamme, Luc, et al.
Publicado: (2020)

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2021)

In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2020)

In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases
por: Shey, Robert Adamu, et al.
Publicado: (2019)

Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring
por: Yengo, Bernis Neneyoh, et al.
Publicado: (2022)

A lipid transfer protein ensures nematode cuticular impermeability
por: Njume, Ferdinand Ngale, et al.
Publicado: (2022)

Entomological Assessment of Onchocerca Species Transmission by Black Flies in Selected Communities in the West Region of Cameroon
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2020)

Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders’ views
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2019)

Do Communities Really “Direct” in Community-Directed Interventions? A Qualitative Assessment of Beneficiaries’ Perceptions at 20 Years of Community Directed Treatment with Ivermectin in Cameroon
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2019)

Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role?
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2021)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2017)

Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate Against Onchocerciasis and Related Filarial Diseases
por: Shey, Robert Adamu, et al.
Publicado: (2021)

Nodding syndrome (NS) and Onchocerca Volvulus (OV) in Northern Uganda
por: Lagoro, David Kitara, et al.
Publicado: (2017)

The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice
por: Hess, Jessica A., et al.
Publicado: (2016)

Linear epitopes in Onchocerca volvulus vaccine candidate proteins and excretory‐secretory proteins
por: Lagatie, Ole, et al.
Publicado: (2018)

Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans
por: George, Parakkal Jovvian, et al.
Publicado: (2019)

Onchocerca - infected cattle produce strong antibody responses to excretory-secretory proteins released from adult male Onchocerca ochengi worms
por: Boursou, Djafsia, et al.
Publicado: (2018)

Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
por: Vlaminck, Johnny, et al.
Publicado: (2019)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
por: Kamga, Guy-Roger, et al.
Publicado: (2018)

Important progress towards elimination of onchocerciasis in the West Region of Cameroon
por: Kamga, Guy-Roger, et al.
Publicado: (2017)

Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
por: Luu, Lisa, et al.
Publicado: (2022)

The Onchocerca volvulus Cysteine Proteinase Inhibitor, Ov-CPI-2, Is a Target of Protective Antibody Response That Increases with Age
por: Cho-Ngwa, Fidelis, et al.
Publicado: (2010)

Human immune responses to infective stage larval-specific chitinase of filarial parasite, Onchocerca volvulus, Ov-CHI-1.
por: Wu, Yang, et al.
Publicado: (2003)

Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus
Publicado: (1995)

Performance evaluation of 3 serodiagnostic peptide epitopes and the derived multi-epitope peptide OvNMP-48 for detection of Onchocerca volvulus infection
por: Lagatie, Ole, et al.
Publicado: (2019)

Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment
por: Kamga, Guy-Roger, et al.
Publicado: (2016)

Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
por: Bourguinat, Catherine, et al.
Publicado: (2007)

Ov2 is a modulator of OvHV-2 RTA mediated gene expression
por: Dry, Inga, et al.
Publicado: (2019)

Nouveau coronavirus (NcOV)
por: Bricaire, François
Publicado: (2013)

Excretory Bacilluria
por: Mack, Wm. S.
Publicado: (1937)

Evaluation of glycoprotein Ov8 as a potential antigen for an OvHV-2-specific diagnostic assay
por: Alhajri, Salim M., et al.
Publicado: (2018)

Deletion of gene OV132 attenuates Orf virus more effectively than gene OV112
por: Yamada, Yumiko, et al.
Publicado: (2022)

African Swine Fever in Cameroon: A Review
por: Ebwanga, Ebanja Joseph, et al.
Publicado: (2021)

Molecular Characterization of ASFV and Differential Diagnosis of Erysipelothrix in ASFV-Infected Pigs in Pig Production Regions in Cameroon
por: Ebwanga, Ebanja Joseph, et al.
Publicado: (2022)

Full mitochondrial and nuclear genome comparison confirms that Onchocerca sp. “Siisa” is Onchocerca ochengi
por: Jaleta, Tegegn G., et al.
Publicado: (2018)

Bacteriome Diversity of Blackflies’ Gut and Association with Onchocerca volvulus, the Causative Agent of Onchocerciasis in Mbam Valley (Center Region, Cameroon)
por: Efon Ekangouo, Arnauld, et al.
Publicado: (2021)

Onchocerca jakutensis Filariasis in Humans
por: Koehsler, Martina, et al.
Publicado: (2007)

The NR3B subgroup: an ovERRview
por: Tremblay, Annie M., et al.
Publicado: (2007)

Dynamics of Onchocerca volvulus Microfilarial Densities after Ivermectin Treatment in an Ivermectin-naïve and a Multiply Treated Population from Cameroon
por: Pion, Sébastien D. S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8arl0eh61kj8ue90kob3tinnao